1例恶性水肿型皮肤炭疽患者的药学监护

Pharmaceutical Care for a Patient with Cutaneous Anthrax of Malignant Edema

目的探讨临床药师对恶性水肿型皮肤炭疽患者的药学监护模式。方法根据恶性水肿型皮肤炭疽患者的药物治疗特点,对患者进行药学监护,针对性提出用药建议。结果通过药学监护,可提高恶性水肿型皮肤炭疽患者用药的安全性、合理性及有效性,减少药物不良反应的发生。结论临床药师积极开展药学服务,协同临床医师优化给药方案,有利于患者用药安全、合理、有效。

OBJECTIVE To discuss the pharmaceutical care model on the patient with cutaneous anthrax of malignant edema. METHODS According to the characteristics of drug therapy on the patient with cutaneous anthrax of malignant edema, the pharmaceutical care was carried out and the suggestions on the pharmacy were given. RESULTS Through the pharmaceutical care, the safety, reasonable and effectiveness were improved. And also, the incidence rate of adverse drug reaction was decreased. CONCLUSION The clinical pharmacists develop actively pharmaceutical service and optimize dosage regimen cooperating with the clinical physician, which is beneficial to the safety, reasonable and effectiveness of drug therapy on the patients.